Michael L. Meyers

Insider Reports History

Location
Waltham, MA
Signature
/s/ Nathan N. McConarty, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Michael L. Meyers:

Company Role Class Num Shares Value Price $ Report Date Ownership
Syndax Pharmaceuticals Inc SVP, Chief Medical Officer Common Stock 23,280 $425,212 $18.27 31 Jan 2022 Direct
Nuvalent, Inc. Director Class A Common Stock 5,146 $343,341 $66.72 18 Jun 2025 Direct
Syndax Pharmaceuticals Inc SVP, Chief Medical Officer Stock Options (Right to buy) 17,350 $335,723 $19.35 02 Feb 2022 Direct
Nuvalent, Inc. Director Stock Option (Right to Buy) 4,147 18 Jun 2025 Direct

Insider Reports Filed by Michael L. Meyers

Symbol Company Period Transactions Value $ Form Type Role Filing Time
NUVL Nuvalent, Inc. 18 Jun 2025 2 $0 4 Director 20 Jun 2025, 16:34
NUVL Nuvalent, Inc. 12 Jun 2024 2 $0 4 Director 14 Jun 2024, 16:10
NUVL Nuvalent, Inc. 15 Jun 2023 1 $0 4 Director 16 Jun 2023, 16:17
NUVL Nuvalent, Inc. 04 Oct 2022 1 $0 4 Director 06 Oct 2022, 16:30
NUVL Nuvalent, Inc. 04 Oct 2022 0 $0 3 Director 06 Oct 2022, 16:25
SNDX Syndax Pharmaceuticals Inc 02 Feb 2022 2 +$295,193 4 SVP, Chief Medical Officer 03 Feb 2022, 16:31
SNDX Syndax Pharmaceuticals Inc 30 Dec 2021 2 +$51,743 4 SVP, Chief Medical Officer 03 Jan 2022, 15:03